饮食中的抗氧化剂摄入与心力衰竭有关:来自NHANES 2003-2019年的结果
Tao Li1, Huangdan Yang2, Lijuan Guo2
1Department of Pathophysiology, Medical College, Jiaying University, Meizhou, China.
Heart & lung : the journal of critical care
|March 8, 2024
概括
通过综合饮食抗氧化剂指数 (CDAI) 测量较高的饮食抗氧化剂摄入量,与美国成年人心力衰竭 (HF) 的风险较低有关. 这表明抗氧化剂可能在预防心力衰竭方面发挥作用.
科学领域:
- 心血管健康 心血管健康
- 营养科学 营养科学
- 流行病学 流行病学
背景情况:
- 越来越多的证据支持抗氧化剂饮食用于预防心力衰竭 (HF).
- 综合饮食抗氧化剂指数 (CDAI) 是饮食抗氧化剂的关键指标.
- 需要进一步调查CDAI和HF之间的关联.
研究的目的:
- 研究综合饮食抗氧化剂指数 (CDAI) 和心力衰竭 (HF) 之间的关系.
主要方法:
- 从2003年到2019年进行的国家健康和营养检查调查 (NHANES) 的二次分析.
- 使用了加权的多变量逻辑回归模型.
- 进行了子组分析和相互作用试验.
主要成果:
- 包括37,390名参与者;HF患者的CDAI水平较低.
- 在CDAI和HF之间发现了负相关性 (OR:0.97,95%CI:0.94-1.00).
- 增加的CDAI显示了一个反向趋势,HF的几率下降 (趋势p<0.001).
结论:
- 在美国成年人中,CDAI与HF相反相关.
- 较高的CDAI水平可能与心力衰竭发病率较低有关.
- 饮食中的抗氧化剂显示出预防心力衰竭的潜力.
更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
19.1K
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
91
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
91